TCRR — TCR2 Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual balance sheet for TCR2 Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	123	158	228	266	149
Prepaid Expenses
Total Other Current Assets
Total Current Assets	125	163	236	276	178
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.64	4.93	10	45.4	28.7
Other Long Term Assets
Total Assets	129	169	246	323	208
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	5.46	7.53	8.84	18.6	64.1
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	5.9	8.08	9.65	41.9	67.4
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	124	160	237	281	141
Total Liabilities & Shareholders' Equity	129	169	246	323	208
Total Common Shares Outstanding